Quick answer

An intangible asset is an identifiable non-monetary resource without physical substance. A purchased licence or separately identifiable software right may qualify, while internally incurred research, development, advertising, and similar costs require different analysis.

The absence of physical form does not make a resource intangible for accounting purposes by itself. The business must control a resource that can be distinguished from the business as a whole, then determine how it arose and which recognition and measurement requirements apply.

Non-monetary means the resource is not itself a right to receive a fixed or determinable number of currency units. Its benefits come from the controlled right or resource, rather than from collecting a specified cash amount.

Identifiable intangible resources

PP&E

A physical resource used in operations, such as a building, vehicle, or machine. See PP&E for its recognition and initial cost.

Identifiable intangible asset

A non-physical resource that can be separated and transferred or that arises from contractual or other legal rights. Software licences, patents, and some customer-related rights can be examples.

Goodwill

The residual in a business combination—when one entity obtains control of a business—that is not separately identifiable. See Goodwill for acquisition measurement and subsequent impairment.

Separability means the resource can be separated from the entity and sold, transferred, licensed, rented, or exchanged. A resource can also be identifiable because it arises from contractual or legal rights even when the entity does not plan to transfer it.

Purchased and internally generated intangibles

A separately purchased right has an observable acquisition price and related costs that can be assessed. Internally incurred spending is more difficult because ordinary effort, training, promotion, research, and development do not automatically create a controlled resource that can be recorded separately from the business.

Research
Investigation aimed at gaining new knowledge before a specific viable application has been demonstrated. Research spending is not treated as a recognized intangible asset merely because management hopes it will lead to a successful product.
Development
Applying knowledge to a plan or design for a new or improved product or process. Development spending can qualify as an asset once specific criteria are met, as the next sections explain.

IFRS recognition of development expenditures

IAS 38 expenses research as incurred. Development expenditure is capitalized only from the date the entity can demonstrate all of the following:

  • Technical feasibility of completing the asset.
  • Intention to complete it and use or sell it.
  • Ability to use or sell it.
  • Probable future economic benefits, supported by a market or internal usefulness.
  • Adequate technical, financial, and other resources to complete and use or sell it.
  • Ability to measure attributable development expenditure reliably.

Previously expensed amounts are not reinstated when the project later qualifies. Only subsequent qualifying expenditure enters the asset.

Separate research from qualifying development

Beacon Medical spends $90,000 investigating alternative sensor designs. On July 1, its selected design passes feasibility testing, management approves and funds completion, a supportable market exists, and the project ledger can reliably identify attributable costs. From July through completion, Beacon incurs $140,000 of directly attributable development costs. It applies IFRS and all IAS 38 recognition criteria are demonstrably met from July 1. Assume both phases are paid immediately in cash.

Journal entryExpense the research phase
Expense the research phase
AccountDebitCredit
Research Expense90,000
90,000
Journal entryCapitalize qualifying development expenditure
Capitalize qualifying development expenditure
AccountDebitCredit
Development Asset140,000
140,000

The $90,000 remains expense. Passing the recognition threshold changes the treatment of later qualifying spending; it does not convert uncertainty that existed earlier into an asset retroactively.

ASPE development policy

ASPE Section 3064 also expenses research, but it permits an entity to choose a policy of expensing development costs or capitalizing them when every recognition condition is met. The policy is applied consistently. If research and development cannot be distinguished, all of the spending is treated as research. Like IFRS, ASPE does not reinstate expenditure that was already expensed merely because the project later succeeds.

Internally generated brands, mastheads, publishing titles, customer lists, and internally generated goodwill are not recognized as assets under IAS 38 or ASPE Section 3064 because their cost cannot be distinguished reliably from developing the business as a whole. A purchased contractual customer relationship or brand can nevertheless be a separately identifiable asset.

Finite and indefinite useful lives

After recognition, the entity determines whether the asset’s useful life is finite or indefinite. That conclusion determines whether the recorded amount is allocated through amortization and how the asset is monitored for impairment.

Finite useful life
The expected benefit has a limited period or output. The asset is amortized over that useful life. See Amortization for the amount, timing, method, entry, and statement effects.
Indefinite useful life
No foreseeable limit is identified under the applicable facts and requirements. “Indefinite” does not mean permanent or immune from impairment and reassessment.

Useful life reflects contractual limits, renewal evidence, technological change, demand, competition, maintenance spending, and dependence on other assets. An indefinite-life conclusion must be reassessed rather than treated as permanent. Separate impairment and recoverability requirements also apply according to the asset and framework.

Common errors

  • Assuming anything non-physical is automatically an intangible asset.
  • Capitalizing internal spending because management expects future benefit.
  • Treating “indefinite” as meaning permanent or exempt from impairment.
  • Applying one framework’s development-cost treatment in another context.